Cargando…

T-cell therapy against cancer mutations

Detalles Bibliográficos
Autores principales:	Tran, Eric, Rosenberg, Steven A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148085/ https://www.ncbi.nlm.nih.gov/pubmed/25046408

Ejemplares similares

Toward cell transfer immunotherapy against patient-specific mutations in gastrointestinal cancers
por: Tran, Eric, et al.
Publicado: (2014)

Immersion in the search for effective cancer immunotherapies
por: Rosenberg, Steven A.
Publicado: (2021)

Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
por: Golubovskaya, Vita
Publicado: (2023)

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression
por: Stevanović, Sanja, et al.
Publicado: (2015)

Cancer Mutational Load: The More the Merrier for Immune Checkpoint Blockade Therapies
Publicado: (2016)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
por: Shepherd, Annemarie F., et al.
Publicado: (2020)

Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer
por: Al Jaberi, Mira, et al.
Publicado: (2023)

Identification and Targeting of Stem Cell-Activated Pathways in Cancer Therapy
por: Budillon, Alfredo, et al.
Publicado: (2019)

The Stockholm Syndrome of Cancer: Fibroblasts as a Powerful Shield against Colorectal Cancer Therapy
por: Tardito, Samuele, et al.
Publicado: (2023)

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

TTF-1 and immune checkpoint therapy in non-small cell lung cancer
por: Gumbleton, Matthew, et al.
Publicado: (2023)

Subtype-specific therapy for autoimmune neuropathies?
por: Lancaster, Eric, et al.
Publicado: (2015)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Gene mutation‐based and specific therapies in precision medicine
por: Wang, Xiangdong
Publicado: (2016)

DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells?
por: Patel, Monal, et al.
Publicado: (2023)

Non-mutational (epigenomic) structural variation in the transcriptome of cancer cells
por: Thompson, E. Aubrey
Publicado: (2015)

Realities of KRAS-mutated non-small cell lung cancer
por: Min, Young Joo
Publicado: (2017)

Dendritic Cell and Cancer Therapy
por: Galati, Domenico, et al.
Publicado: (2023)

Antidepressants synergize with chemotherapy against cancer stem cells
por: Melino, Gerry
Publicado: (2015)

Special Issue “Gamma Delta T Cells in Immune Response against Viruses”
por: Champagne, Eric
Publicado: (2022)

CDK4/6 inhibition protects normal cells against cancer therapy-induced damage
por: Boopathi, Ettickan, et al.
Publicado: (2020)

Treatment strategy of EGFR-mutated non-small cell lung cancer
por: Tanaka, Fumihiro, et al.
Publicado: (2022)

Editorial: Recent Approval of Sotorasib as the First Targeted Therapy for KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Parums, Dinah V.
Publicado: (2022)

Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer
por: Narod, Steven A.
Publicado: (2023)

Aging, stem cells and cancer updated
por: Elkashty, Osama A., et al.
Publicado: (2021)

Stem Cells in Cancer Progression and Therapy
por: Tan, Hua, et al.
Publicado: (2019)

The Campaign against Cancer
Publicado: (1915)

Cancer stem cells, the ultimate targets in cancer therapy
por: Shabbir, Ahmed, et al.
Publicado: (2018)

An allogeneic NK cell line engineered to express chimeric antigen receptors: A novel strategy of cellular immunotherapy against cancer
por: Badoual, Cécile, et al.
Publicado: (2013)

Critical points in the management of EGFR-mutated non-small cell lung cancer
por: Casaluce, Francesca, et al.
Publicado: (2022)

Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed
por: Shen, James L., et al.
Publicado: (2022)

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
por: Parkhurst, Maria, et al.
Publicado: (2015)

ESR1 mutations in breast cancer
por: Clatot, Florian, et al.
Publicado: (2017)

Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease
por: Feng, Han-Rong, et al.
Publicado: (2018)

Complex EGFR mutations in non-small cell lung cancer: a distinct entity?
por: Bieńkowski, Michał, et al.
Publicado: (2022)

Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer Therapy
por: Sharma, Nidhi, et al.
Publicado: (2023)

The Fight Against Cervical Cancer
Publicado: (2015)

The continuing search for cancer-causing somatic mutations
por: Dalgliesh, Gillian L, et al.
Publicado: (2007)

Mutation hotspots in cis-regulatory regions in cancer
por: Poulos, Rebecca C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i6qt4i122t00naq6skclg1os52